CIR and OS based on the residual status either of serum ctDNA or mutation in BM. CIR and OS according to residual status either of serum ctDNA (A-B) or mutation in BM (C-D) at 1 month post-alloSCT. CIR and OS according to residual status either of serum ctDNA (E-F) or mutation in BM (G-H) at 3 months post-alloSCT.